4//SEC Filing
Murphy Michael R 4
Accession 0001312548-12-000044
CIK 0001323885other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 5:24 PM ET
Size
12.4 KB
Accession
0001312548-12-000044
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Discovery Group I, LLC
10% Owner
Transactions
- Sale
Common Stock
2012-11-26$7.16/sh−6,781$48,561→ 235,744 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-27$7.00/sh−200$1,400→ 1,792,559 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-28$6.81/sh−464$3,160→ 1,792,095 total(indirect: By Pleiades Investment Partners - D, L.P)
Donoghue Daniel J
10% Owner
Transactions
- Sale
Common Stock
2012-11-28$6.81/sh−464$3,160→ 1,792,095 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-27$7.00/sh−200$1,400→ 1,792,559 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-26$7.16/sh−6,781$48,561→ 235,744 total(indirect: By Pleiades Investment Partners - D, L.P)
Murphy Michael R
10% Owner
Transactions
- Sale
Common Stock
2012-11-28$6.81/sh−464$3,160→ 1,792,095 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-26$7.16/sh−6,781$48,561→ 235,744 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-27$7.00/sh−200$1,400→ 1,792,559 total(indirect: By Pleiades Investment Partners - D, L.P)
Footnotes (3)
- [F1]Discovery Group I, LLC is an investment manager for Pleiades Investment Partners - D, L.P., which is a discretionary client of the reporting person, that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F2]This transaction was executed in multiple trades at prices ranging from $7.14 - $7.21. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- [F3]This transaction was executed in multiple trades at prices ranging from $6.80 - $6.85. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001323510
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 5:24 PM ET
- Size
- 12.4 KB